PDE4A and inflammatory bowel disease: Our data elucidates a function of PRKAR2A deficiency in ameliorating DSS-induced colitis, which was earlier unidentified, thus suggesting that PRKAR2A might contribute to the unsatisfactory results of PDE4 inhibitor in the IBD clinical trial.